All News

Vemurafenib (Zelboraf) receives priority review for Erdheim-Chester Disease.

New Drug Applications filed for halobetasol propionate and tazarotene lotion, a topical treatment for plaque psoriasis.

Officials with the FDA have extended the approval of vemurafenib (Zelboraf, Genentech) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare blood cancer, making it the first approved treatment for ECD.

In this clip, Kathy Campbell, PharmD, CEO of Medicap Pharmacy, discusses the benefits of interacting with patients about their wellness and offering weight management services in the pharmacy.

An aspirin a day may reduce their risk of hepatocellular carcinoma in patients with hepatitis B virus.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Focus on these 5 mental mantras and watch your community pharmacy practice improve like no other.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

A look at last week's top stories in the world of pharmacy.

Elevated levels of high-density lipoprotein may not be beneficial for the heart.

Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.

Hospital groups say that changes to the 340B program threaten access to treatment for Medicare beneficiaries.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

High-dose omega-3 fatty acids during the third trimester of pregnancy could prevent respiratory problems.

Vaccine coverage lowest among children who were uninsured or covered by Medicaid compared with children who had private insurance.

Vedolizumab (Entyvio) remains consistent in its safety profile in study of real-world data on ulcerative colitis and Crohn's disease.

Top news of the week from Specialty Pharmacy Times.

Meant as a curricular assessment, this test could hurt colleges and students unexpectedly

Pharmacy Times took to social media this October to celebrate American Pharmacists Month with our annual #ThankAPharmacist campaign. Here are the 10 noteworthy posts from Facebook, Twitter, and Instagram using the hashtag.

Unapproved products containing cannabidiol claim to prevent or cure cancer.

Advocacy groups praise policy change towards reforming 340B and reducing drug costs for seniors.

Changes to 340B reimbursement will drastically lower out-of-pocket costs for Medicare beneficiaries.

Proton pump inhibitors may lead to an imbalance of Enterococcus bacteria and increase the risk of liver injury.

Glucose is crucial for the growth of brain cancer cells.